Pharmala Biotech Holdings Inc.
MDMA
CNSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.74% | -22.75% | -13.47% | 638.32% | -54.41% |
| Total Receivables | 491.21% | -52.26% | -14.99% | -19.06% | -11.56% |
| Inventory | -4.87% | -3.20% | 16.61% | -5.51% | -3.70% |
| Prepaid Expenses | -96.05% | 229.00% | 10.41% | 118.45% | -46.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.78% | -10.19% | -7.79% | 160.41% | -28.10% |
|
|
|||||
| Total Current Assets | -1.78% | -10.19% | -7.79% | 160.41% | -28.10% |
| Net Property, Plant & Equipment | -9.52% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.70% | -1.26% | 3.66% | -4.64% | -3.93% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -2.26% | -5.69% | -2.47% | 44.26% | -12.65% |
|
|
|||||
| Total Accounts Payable | -17.75% | 27.01% | 26.70% | 36.35% | -52.18% |
| Total Accrued Expenses | -- | -- | -- | -64.20% | -14.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 36.73% | -7.39% | 4.21% | -3.37% | 15.93% |
| Total Other Current Liabilities | 36.73% | -7.39% | 4.21% | -3.37% | 15.93% |
| Total Current Liabilities | 5.04% | 9.92% | 13.17% | 8.77% | -23.84% |
|
|
|||||
| Total Current Liabilities | 5.04% | 9.92% | 13.17% | 8.77% | -23.84% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.04% | 9.92% | 13.17% | 8.77% | -23.84% |
|
|
|||||
| Common Stock & APIC | 2.14% | 0.91% | 7.31% | 13.17% | 2.22% |
| Retained Earnings | -3.99% | -5.47% | -13.72% | -11.56% | -5.63% |
| Treasury Stock & Other | -1.67% | 0.13% | 4.90% | 213.29% | -3.69% |
| Total Common Equity | -5.12% | -10.66% | -6.57% | 57.78% | -7.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.12% | -10.66% | -6.57% | 57.78% | -7.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.12% | -10.66% | -6.57% | 57.78% | -7.46% |
|
|
|||||